Senior insider sale
Chief Financial Officer at PROTAGONIST THERAPEUTICS, INC — senior position signals high conviction
$6.61M
72.72K shares
What this filing means
ALI ASIF plans to sell 72.72K shares of PROTAGONIST THERAPEUTICS, INC valued at approximately $6.61M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/21/2026ACC: 0001104659-26-046107
Officer· Chief Financial Officer
Since Apr 2022
72.72K
Shares to sell
$6.61M
Approx. market value
1.75K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Services Rendered
4/20/2026
1.75KTotal acquired1.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/20/2026 | Restricted stock vesting under a registered plan Services Rendered | 1.75K | — |
| Total | 1.75K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
24.77K
Market value
$2.58M
3/26/2026
—Completed
Units to sell
46.20K
Market value
$3.84M
1/27/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.75K
Market value
$184.6K
4/20/2026
Total
Units
72.72K
Value
$6.61M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/26/2026 | 24.77K | $2.58M | — | Completed |
1/27/2026 | 46.20K | $3.84M | — | Completed |
| Planned — Approximate Date | ||||
4/20/2026 | 1.75K | $184.6K | NASDAQ | Planned |
| Total | 72.72K | $6.61M | ||